Your browser doesn't support javascript.
loading
Age Patterns of HSV-2 Incidence and Prevalence in Two Ugandan Communities: A Catalytic Incidence Model Applied to Population-Based Seroprevalence Data.
Whittles, Lilith K; Galiwango, Ronald M; Mpagazi, Josephine; Tobian, Aaron A R; Ssekubugu, Robert; Jackson, Jade; Peer, Austin D; Kennedy, Caitlin; Nakalanzi, Margaret; Ndyanabo, Anthony; Kigozi, Godfrey; Chang, Larry W; Serwadda, David; Manabe, Yukari C; Gaydos, Charlotte A; Laeyendecker, Oliver; Quinn, Thomas C; Reynolds, Steven J; Kagaayi, Joseph; Eaton, Jeffrey W; Grabowski, M Kate.
Afiliação
  • Whittles LK; Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
  • Galiwango RM; Medical Research Council Centre for Global Infectious Disease Analysis, and NIHR Health Protection Research Unit in Modelling and Health Economics, School of Public Health, Imperial College London, London, United Kingdom.
  • Mpagazi J; Rakai Health Sciences Program, Kalisizo, Uganda.
  • Tobian AAR; Rakai Health Sciences Program, Kalisizo, Uganda.
  • Ssekubugu R; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Jackson J; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Peer AD; Rakai Health Sciences Program, Kalisizo, Uganda.
  • Kennedy C; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Nakalanzi M; Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Ndyanabo A; Rakai Health Sciences Program, Kalisizo, Uganda.
  • Kigozi G; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Chang LW; Rakai Health Sciences Program, Kalisizo, Uganda.
  • Serwadda D; Rakai Health Sciences Program, Kalisizo, Uganda.
  • Manabe YC; Rakai Health Sciences Program, Kalisizo, Uganda.
  • Gaydos CA; Rakai Health Sciences Program, Kalisizo, Uganda.
  • Laeyendecker O; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Quinn TC; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Reynolds SJ; Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Kagaayi J; Rakai Health Sciences Program, Kalisizo, Uganda.
  • Eaton JW; Department of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda.
  • Grabowski MK; Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
J Infect Dis ; 228(9): 1198-1207, 2023 11 02.
Article em En | MEDLINE | ID: mdl-37079374
ABSTRACT

BACKGROUND:

Herpes simplex virus type 2 (HSV-2) is an incurable sexually transmitted infection associated with increased risk of acquiring and transmitting human immunodeficiency virus (HIV). HSV-2 is highly prevalent in sub-Saharan Africa, but population-level estimates of incidence are sparse.

METHODS:

We measured HSV-2 prevalence from cross-sectional serological data among adults aged 18-49 years in 2 south-central Uganda communities (fishing, inland). We identified risk factors for seropositivity, then inferred age patterns of HSV-2 with a Bayesian catalytic model.

RESULTS:

HSV-2 prevalence was 53.6% (n = 975/1819; 95% confidence interval, 51.3%-55.9%). Prevalence increased with age, was higher in the fishing community, and among women, reaching 93.6% (95% credible interval, 90.2%-96.6%) by age 49 years. Factors associated with HSV-2 seropositivity included more lifetime sexual partners, HIV positive status, and lower education. HSV-2 incidence peakied at age 18 years for women and 19-20 years for men. HIV prevalence was up to 10-fold higher in HSV-2-positive individuals.

CONCLUSIONS:

HSV-2 prevalence and incidence were extremely high, with most infections occurring in late adolescence. Interventions against HSV-2, such as future vaccines or therapeutics, must target young populations. Remarkably higher HIV prevalence among HSV-2-positive individuals underscores this population as a priority for HIV prevention.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Herpes Genital / Infecções por HIV / Soropositividade para HIV Tipo de estudo: Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: J Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Herpes Genital / Infecções por HIV / Soropositividade para HIV Tipo de estudo: Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: J Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido